Position
Chief Business Officer
Company
MBX Biosciences, Inc.
CarmelBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
MBX Biosciences today announced the appointment of Karen Basbaum as Chief Business Officer. Ms. Basbaum brings over two decades of leadership experience in corporate strategy and business development across the biotechnology and pharmaceutical industries.
Quick answer
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026). MBX Biosciences, Inc. is based in Carmel, Indiana, United States.
- Who is the new Chief Business Officer at MBX Biosciences, Inc?
- MBX Biosciences, Inc. named Karen Basbaum Chief Business Officer, announced March 10, 2026.
- What did MBX Biosciences, Inc. announce on March 10, 2026?
- MBX Biosciences today announced the appointment of Karen Basbaum as Chief Business Officer. Ms. Basbaum brings over two decades of leadership experience in corporate strategy and business development across the biotechnology and pharmaceutical industries.
- What does MBX Biosciences, Inc. do?
- MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine disorders live fuller and healthier lives.
- Where is MBX Biosciences, Inc. based?
- MBX Biosciences, Inc. is based in Carmel, Indiana, United States.
- Which similar companies made leadership changes around the same time?
- Aquestive Therapeutics, Inc. (March 20, 2026), Santhera Pharmaceuticals (March 10, 2026), AEON Biopharma (March 9, 2026) and Royalty Pharma plc (March 3, 2026) also announced leadership changes within 45 days of MBX Biosciences, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026)
- AEON Biopharma Appoints John Bencich as Chief Financial Officer (March 9, 2026)
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia (March 3, 2026)
- Atossa Therapeutics Appoints Kathy Puyana Theall and Adebola Giwa as Medical Directors (March 19, 2026)
- Aurinia Pharmaceuticals Appoints Kevin Tang as Chief Executive Officer and Ryan Cole as Chief Operating Officer (March 23, 2026)
Who to call at MBX Biosciences, Inc., and when
A new leader at MBX Biosciences, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day MBX Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MBX Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MBX Biosciences, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MBX Biosciences, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MBX Biosciences, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.